查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1836316

感觉异常治疗市场，按类型、按治疗、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Paresthesia Treatment Market, By Type, By Treatment, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年感觉异常治疗市场规模价值 60.521 亿美元，2025 年至 2032 年的复合年增长率为 4.20%。

感觉异常是一种以灼热感、刺痛感、麻木感或刺痛感等感觉为特征的疾病，主要影响手、脚、手臂或腿等身体部位。这种疾病最常见的原因是神经损伤或压迫，导致正常的讯号传输中断，或由脑部血流不稳定引起。感觉异常是多种潜在疾病的症状，包括第1型和第2型糖尿病、维生素缺乏症、神经系统疾病和腕隧道症候群。

感觉异常治疗市场-市场动态

慢性病发生率上升

慢性疾病的盛行率不断上升，推动了感觉异常治疗市场的发展。糖尿病、多发性硬化症和关节炎常会造成神经损伤，导致刺痛、麻木和疼痛等感觉异常症状。随着确诊这些疾病的人数不断增加，对有效缓解感觉异常的治疗方法的需求也日益增长。这种需求的激增迫使医疗保健提供者和製药公司投资于创新方法和标靶疗法。对改善患者生活品质和有效控制症状的重视加速了市场成长，推动了这些慢性疾病治疗方案的进步。

感觉异常治疗市场-細項分析：

全球感觉异常治疗市场根据类型、治疗、最终用户和地区进行细分。

根据类型，市场分为两类：急性感觉异常和慢性感觉异常。由于全球老龄人口迅速增加，急性感觉异常细分市场预计将在研究期间增长最快，而老龄人口更容易患上由退化性脊椎疾病和关节炎引起的神经压迫等疾病。此外，医疗技术的快速进步带来了更有效、更侵入性的急性感觉异常治疗方法的开发，预计将推动细分市场的成长。根据世界卫生组织的数据，2020 年 60 岁以上的人口约有 10 亿，预计到 2030 年将上升到 14 亿以上。此外，到 2050 年，80 岁及以上人口数量将翻倍，达到 21 亿以上。

根据治疗类型，市场可分为四类：免疫抑制剂、外用药膏、抗病毒药物和抗惊厥药物。就收入份额而言，抗惊厥药物将在2025年占据市场主导地位，这得益于其在治疗神经性疼痛（常伴有感觉异常）方面的高效性，以及其更佳的安全性，使其比其他类型的药物更适合长期使用。此外，领先的製药公司正增加对新型抗惊厥药物的研发投入，以期提高疗效并减少副作用，同时探索其与其他疗法（例如物理疗法和其他类型的药物）的联合应用及其潜力，这可能会拓宽治疗选择，并进一步推动抗惊厥药物市场的发展。

感觉异常治疗市场—地理洞察

北美占据全球市场主导地位。该地区市场的成长主要得益于治疗技术进步的普及，以及该地区多种神经系统疾病的盛行率上升。此外，该地区拥有完善的监管机构，例如美国食品药物管理局 (FDA)，为新医疗器材和新疗法的审批提供了清晰的路径，鼓励了该领域的创新，并为市场创造了巨大的成长潜力。例如，2022年4月，BioXcel Therapeutics宣布FDA已批准IGALMI舌下膜，该膜专为急性躁动治疗设计。这是FDA核准的首个用于治疗中度至重度躁动患者的口溶性舌下膜。

预计亚太市场在预测期内成长最快。该市场主要受完善的医疗保健系统和对神经系统疾病的广泛认知所推动。此外，医疗保健投资增加等因素预计将在预测期内推动亚太地区的市场成长。例如，2024年3月，Wipro GE Healthcare宣布投资超过8亿美元，以因应不断扩大的国内外医疗保健市场。

感觉异常治疗市场-竞争格局：

感觉异常治疗市场竞争激烈，许多全球和地区参与者争夺市场份额。产品创新、策略合作、併购以及经销网络的扩张都会影响市场竞争力。各公司正致力于开发新疗法并改进现有治疗方案，以改善患者疗效并获得竞争优势。此外，研发和临床试验的投资对于将新型有效疗法推向市场至关重要。感觉异常治疗市场的主要参与者包括史赛克公司、百特国际公司、生物医学研究有限公司和波士顿科学公司。

目录

第一章：感觉异常治疗市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 感觉异常治疗市场依产品类型划分
    • 感觉异常治疗市场片段（按治疗）
    • 感觉异常治疗市场片段（按最终用户）
    • 感觉异常治疗市场（按国家/地区）
    • 感觉异常治疗市场（按地区）
  • 竞争洞察

第三章：感觉异常治疗的主要市场趋势

  • 感觉异常治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 感觉异常治疗市场限制
    • 市场限制的影响分析
  • 感觉异常治疗市场机会
  • 感觉异常治疗市场未来趋势

第四章：感觉异常治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：感觉异常治疗市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：感觉异常治疗市场格局

  • 2024年感觉异常治疗市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：感觉异常治疗市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 急性感觉异常
    • 慢性感觉异常

第 8 章：感觉异常治疗市场 - 按治疗

  • 概述
    • 按治疗方式分類的细分市场占有率分析
    • 免疫抑制剂
    • 外用药膏
    • 抗病毒药物
    • 抗惊厥药

第九章：感觉异常治疗市场－按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 诊断中心
    • 诊所

第 10 章：感觉异常治疗市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美感觉异常治疗主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模及预测（按治疗类型）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲感觉异常治疗主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模及预测（按治疗类型）
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区（APAC）
    • 概述
    • 亚太地区感觉异常治疗主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依治疗类型）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲感觉异常治疗主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（依治疗类型）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲感觉异常治疗主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（以处理方式）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：关键供应商分析-感觉异常治疗产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Stryker Corporation
    • Baxter International Inc.
    • Bio-Medical Research Ltd.
    • Boston Scientific Corporation
    • Cipla Ltd.
    • ElectroCore LLC
    • Abbott Laboratories
    • EnteroMedics Inc.
    • Nevro Corporation
    • Medtronic Plc
    • Omron Healthcare Inc.
    • Pfizer
    • St. Jude Medical LLC
    • Stimwave LLC
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5606

Paresthesia Treatment Market size was valued at US$ 6,052.10 Million in 2024, expanding at a CAGR of 4.20% from 2025 to 2032.

Paresthesia is a medical condition characterized by sensations like burning, tingling, numbness, or prickling that primarily affect various body parts such as the hands, feet, arms, or legs. The condition is most commonly caused by nerve damage or compression, which disrupts normal signal transmission, or by inconsistent blood flow to and from the brain. Paresthesia is a symptom of a variety of underlying medical conditions, including type 1 and type 2 diabetes, vitamin deficiencies, neurological disorders, and carpal tunnel syndrome.

Paresthesia Treatment Market- Market Dynamics

Increasing Incidences of Chronic Illnesses

The rising prevalence of chronic illnesses is driving the paresthesia treatment market. Diabetes, multiple sclerosis, and arthritis frequently cause nerve damage, resulting in paresthesia symptoms such as tingling, numbness, and pain. As the number of people diagnosed with these disorders rises, so does the demand for effective treatments to relieve paresthesia. This surge in demand forces healthcare providers and pharmaceutical companies to invest in novel approaches and targeted therapies. The primary focus on improving patient quality of life and effectively managing symptoms accelerates market growth, driving advancements in treatment options for these chronic conditions.

Paresthesia Treatment Market- Key Insights

According to our research analyst's analysis, the global market is expected to grow at a compound annual growth rate (CAGR) of approximately 4.20% during the 2025-2032 forecast period.

According to type segmentation, the acute paresthesia segment is expected to grow at the fastest rate during the study period.

The anticonvulsants segment held the largest share of the market in 2025, according to treatment segmentation.

In 2025, North America was the top revenue-generating region by region.

Paresthesia Treatment Market- Segmentation Analysis:

The Global Paresthesia Treatment Market is segmented on the basis of Type, Treatment, End-User, and Region.

The market is divided into two categories based on Type: Acute Paresthesia, and Chronic Paresthesia. The acute paresthesia segment is expected to grow the most during the study period, owing to the rapid increase in the global aging population, which is more likely to suffer from conditions such as nerve compression caused by degenerative spinal conditions and arthritis. Furthermore, rapid advances in medical technology, which are leading to the development of more effective and less invasive treatment options for acute paresthesia, are expected to drive segment market growth. According to the World Health Organization, there were approximately 1 billion people over the age of 60 in 2020, and this figure is expected to rise to over 1.4 billion by 2030. Furthermore, the number of people aged 80 and up will double by 2050, reaching over 2.1 billion.

The market is divided into four categories based on Treatment: Immunosuppressants, Topical Creams, Antivirals, and Anticonvulsants. In terms of revenue share, the anticonvulsants segment dominates the market in 2025, owing to their high effectiveness in managing neuropathic pain, which frequently involves paresthesia, as well as their more favorable safety profile, which makes them suitable for long-term use over other types of medications. Furthermore, leading pharmaceutical companies are increasingly investing heavily in the development of new anticonvulsant medications with improved efficacy and fewer side effects, as well as exploring their use and potential in conjunction with other treatments such as physical therapy and other types of medications, which is likely to broaden treatment options and further drive the anticonvulsant segment.

Paresthesia Treatment Market- Geographical Insights

North America dominates the global market. The regional market growth is primarily due to increased adoption of technological advances in treatment techniques and a higher prevalence of several neurological conditions throughout the region. Furthermore, the region has well-established regulatory bodies such as the FDA, which provides a clear path for the approval of new medical devices and treatments, encouraging innovation in this field and creating enormous growth potential for the market. For example, in April 2022, BioXcel Therapeutics announced that the FDA had approved the IGALMI Sublingual Film, which is specifically designed for the acute treatment of agitation. This is the first FDA-approved orally dissolving sublingual film designed for moderate to severe agitation in patients.

The Asia Pacific market is expected to grow the fastest during the forecast period. The market is primarily driven by a well-established healthcare system and widespread awareness of neurological disorders. In addition, factors such as increased healthcare investment and others are expected to drive market growth in the Asia Pacific region over the forecast period. For instance, in March 2024, Wipro GE Healthcare announced an investment of more than USD 800 million to address the expanding domestic and international healthcare markets.

Paresthesia Treatment Market- Competitive Landscape:

The paresthesia treatment market is characterized by a competitive landscape, with many global and regional players vying for market share. Product innovation, strategic collaborations, mergers and acquisitions, and expanding distribution networks all have an impact on market competitiveness. Companies are focusing on developing new therapies and improving existing treatment protocols in order to improve patient outcomes and gain a competitive advantage. Additionally, investments in R&D and clinical trials are critical for bringing new and effective treatments to market. Major players in the paresthesia treatment market include Stryker Corporation, Baxter International Inc., Bio-Medical Research Ltd., and Boston Scientific Corporation.

Recent Developments:

In October 2023, Boston Scientific Corporation received approval from the U.S. FDA for usage of the Wave Writer Alpha Spinal Cord Stimulator (SCS) Systems to treat painful diabetic peripheral neuropathy (DPN).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PARESTHESIA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Stryker Corporation
  • Baxter International Inc.
  • Bio-Medical Research Ltd.
  • Boston Scientific Corporation
  • Cipla Ltd.
  • ElectroCore LLC
  • Abbott Laboratories
  • EnteroMedics Inc.
  • Nevro Corporation
  • Medtronic Plc
  • Omron Healthcare Inc.
  • Pfizer
  • St. Jude Medical LLC
  • Stimwave LLC
  • Others

GLOBAL PARESTHESIA TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Acute Paresthesia
  • Chronic Paresthesia

GLOBAL PARESTHESIA TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Immunosuppressants
  • Topical Creams
  • Antivirals
  • Anticonvulsants

GLOBAL PARESTHESIA TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnosis Centers
  • Clinics

GLOBAL PARESTHESIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Paresthesia Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Paresthesia Treatment Market Snippet by Product Type
    • 2.1.2. Paresthesia Treatment Market Snippet by Treatment
    • 2.1.3. Paresthesia Treatment Market Snippet by End-User
    • 2.1.4. Paresthesia Treatment Market Snippet by Country
    • 2.1.5. Paresthesia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Paresthesia Treatment Key Market Trends

  • 3.1. Paresthesia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Paresthesia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Paresthesia Treatment Market Opportunities
  • 3.4. Paresthesia Treatment Market Future Trends

4. Paresthesia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Paresthesia Treatment Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Paresthesia Treatment Market Landscape

  • 6.1. Paresthesia Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Paresthesia Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Acute Paresthesia
    • 7.1.3. Chronic Paresthesia

8. Paresthesia Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2024 & 2032 (%)
    • 8.1.2. Immunosuppressants
    • 8.1.3. Topical Creams
    • 8.1.4. Antivirals
    • 8.1.5. Anticonvulsants

9. Paresthesia Treatment Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnosis Centers
    • 9.1.4. Clinics

10. Paresthesia Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Paresthesia Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Paresthesia Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Paresthesia Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Paresthesia Treatment Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Paresthesia Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Paresthesia Treatment Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Stryker Corporation
    • 11.2.2. Baxter International Inc.
    • 11.2.3. Bio-Medical Research Ltd.
    • 11.2.4. Boston Scientific Corporation
    • 11.2.5. Cipla Ltd.
    • 11.2.6. ElectroCore LLC
    • 11.2.7. Abbott Laboratories
    • 11.2.8. EnteroMedics Inc.
    • 11.2.9. Nevro Corporation
    • 11.2.10. Medtronic Plc
    • 11.2.11. Omron Healthcare Inc.
    • 11.2.12. Pfizer
    • 11.2.13. St. Jude Medical LLC
    • 11.2.14. Stimwave LLC
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us